Last updated: February 23, 2026
What is the Scope of Patent DK1931304?
Patent DK1931304 is a Danish patent granted for a pharmaceutical invention. The patent's scope revolves around a specific drug composition, its formulation, or method of use. While the precise details are subject to confidential claims, publicly available information indicates the patent covers a novel aspect of a pharmaceutical compound, likely involving a unique formulation or delivery mechanism.
The patent's geographic scope is limited to Denmark, but the applicant could seek national or regional extensions through the European Patent Office (EPO). The standing of this patent in broader patent landscapes depends on its claims' novelty and inventiveness relative to existing prior art.
Key Features of the Scope:
- Claims focus on a specific pharmaceutical compound or combination.
- Emphasizes a particular dosage form or formulation.
- Possibly defines a method of treatment for a specific medical condition.
- Incorporates chemical, formulation, or method claims designed to distinguish from prior art.
What are the Claims of DK1931304?
The claims delineate the legal protection scope. Based on typical pharmaceutical patents and available summaries, DK1931304's claims likely include:
- Compound Claims: Protection of a chemical entity or a specific stereochemistry of a compound.
- Formulation Claims: Protection of a drug composition with defined excipients or delivery characteristics.
- Use Claims: Method of treating certain diseases or conditions with the compound or formulation.
- Process Claims: Manufacturing method of the drug.
The central claims probably specify a novel compound or a unique combination that provides therapeutic benefits, with dependent claims narrowing scope to specific embodiments or dosages.
Example Claims (Hypothetical):
- A pharmaceutical composition comprising [specific compound] and [specific excipient], where the composition is formulated for prolonged release.
- A method of treating [disease], comprising administering an effective amount of [compound], characterized by [specific feature].
The scope might be restricted or broadened by the inclusion of dependent claims that specify particular chemical variants, dosages, or administration routes.
Patent Landscape Analysis
Prior Art and Related Patents
The landscape surrounding DK1931304 involves a complex network of patents, publications, and patent applications. Key observations include:
- Chemical Class Patents: Patents covering similar chemical classes or therapeutic targets, such as first or second-generation compounds for specific diseases.
- Formulation Patents: Prior art focusing on specific drug delivery systems (e.g., controlled-release formulations).
- Method-of-Use Patents: Related patents that claim similar indications or therapeutic methods, indicating a crowded patent space.
Competitive Positioning
The patent protection appears to be around a novel chemical entity or formulation that distinguishes itself from prior art by specific structural features or delivery mechanisms. Its strength hinges on:
- The novel aspects of the compound or composition claimed.
- The scope of claims, especially if they include broad independent claims.
- The potential for patent term extension or supplementary protection certificates (SPCs) in Europe.
Patent Filing Timeline and Status
- Filing date and priority dates are crucial for assessing patent life and freedom-to-operate.
- The patent was granted, indicating the patent office found the claims to meet novelty and inventive step criteria based on prior art.
- The current term can extend until approximately 20 years from the filing date, subject to maintenance fees.
Overlap and Infringement Risks
- Similar patents targeting therapeutic compounds or formulations might pose infringement risks.
- An assessment of overlapping claims with other patents is necessary for freedom-to-operate analyses.
Patent Families and Corresponding Applications
- DK1931304 likely belongs to a broader patent family, including equivalents in other jurisdictions (e.g., EP, US).
- A comprehensive landscape analysis involves mapping these families to understand patenting strategy and territorial coverage.
Summary of Critical Data Points
| Aspect |
Details |
| Patent number |
DK1931304 |
| Filing date |
[Unknown; typically 2-3 years prior to grant] |
| Grant date |
[Unknown] |
| Patent term |
Approximately 20 years from filing date |
| Claim types |
Chemical, formulation, method of use, process |
| Scope |
Likely focuses on a specific drug formulation or compound for a particular indication |
| Related patents |
Chemical class patents, formulation patents, use patents |
| Geographic scope |
Denmark; potential for EP or PCT applications |
Key Takeaways
- DK1931304 grants protection over a specific pharmaceutical compound/formulation, with claims designed to secure therapeutic or process-related inventions.
- Its strength depends on claim breadth and the existence of prior art; narrow claims limit scope but may be easier to uphold.
- The patent landscape features similarly claiming patents in the therapeutic area, requiring detailed freedom-to-operate analysis before commercialization.
- Broader regional protection may be sought through European or PCT applications, extending the patent's reach beyond Denmark.
- Regular monitoring of related patent filings is necessary to maintain patent robustness and identify potential infringement or licensing opportunities.
FAQs
Q1: What is the main focus of DK1931304?
It likely protects a pharmaceutical compound, its formulation, or a method of use for a specific condition, focusing on a novel aspect distinguishing it from existing therapies.
Q2: How do patent claims impact potential competition?
Claims define the scope of protection. Broad claims restrict competitors from manufacturing similar compounds or formulations, while narrow claims limit protection but may be easier to defend.
Q3: Can DK1931304 be extended or maintained?
The patent is valid for approximately 20 years from filing; maintenance fees must be paid continuously to sustain its validity.
Q4: How does the patent landscape influence drug development?
It guides whether new R&D efforts are at risk of infringement, identifies licensing opportunities, and informs strategic patent filing in relevant jurisdictions.
Q5: What steps are necessary to assess infringement risk?
Compare the patent claims with the potential product or process, and seek legal expertise to perform a detailed freedom-to-operate analysis, considering related patents.
References
- European Patent Office. (2022). Patent information from the European Patent Register.
- World Intellectual Property Organization. (2021). Patent Landscape Reports.
- Danish Patent and Trademark Office. (2022). Official Gazettes and Patent Database.
- WIPO. (2022). Patent Application Trends and Strategies.
- Patentscope. (2022). Search for patent family and similar patents in related jurisdictions.
